SML – Appendix 3B
+ See chapter 19 for defined terms.
04/03/2013 Appendix 3B Page 1
ME_138344974_1
Rule 2.7, 3.10.3, 3.10.4, 3.10.5
Appendix 3B
New issue announcement,
application for quotation of additional securities
and agreement
Information or documents not available now must be given to ASX as soon as available. Information and
documents given to ASX become ASX’s property and may be made public.
Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12,
04/03/13
Name of entity
Synlait Milk Limited (Synlait)
ARBN
614 984 655
We (the entity) give ASX the following information.
Part 1 - All issues
You must complete the relevant sections (attach sheets if there is not enough space).
1
+
Class of
+
securities issued or to
be issued
Performance Share Rights
2 Number of
+
securities issued or
to be issued (if known) or
maximum number which may
be issued
253,154 Performance Share Rights
3 Principal terms of the
+
securities
(e.g. if options, exercise price
and expiry date; if partly paid
+
securities, the amount
outstanding and due dates for
payment; if
+
convertible
securities, the conversion price
and dates for conversion)
Each Performance Share Right converts on a
1:1 basis for nil consideration into fully paid
ordinary shares in Synlait, subject to the
participant remaining employed and vesting
of the Performance Share Rights on a
progressive scale dependent on Synlait's
TSR and EPS growth over a 3 year vesting
period. Vesting is also subject to pro-rata
scaling if the total value of all Performance
Share Rights vesting in a given calendar year
exceeds 5% of the increase in market
capitalisation over the vesting period.
Performance Share Rights are non-
transferable and have no voting or other
share rights and are otherwise subject to the
rules of the Synlait Employee Share Scheme
and individual award agreements.
4 Do the
+
securities rank equally
in all respects from the
+
issue
date with an existing
+
class of
quoted
+
securities?
If the additional
+
securities do
not rank equally, please state:
the date from which they do
the extent to which they
participate for the next
dividend, (in the case of a
trust, distribution) or
interest payment
the extent to which they do
not rank equally, other than
in relation to the next
dividend, distribution or
interest payment
N/A
5 Issue price or consideration
Nil
6 Purpose of the issue
(If issued as consideration for
the acquisition of assets, clearly
identify those assets)
Issue of Performance Share Rights to certain
directors and management of Synlait under
the Synlait Employee Share Scheme as part
of employee remuneration.
+ See chapter 19 for defined terms.
04/03/2013 Appendix 3B Page 3
ME_138344974_1
6a Is the entity an
+
eligible entity
that has obtained security
holder approval under rule 7.1A?
If Yes, complete sections 6b – 6h
in relation to the
+
securities the
subject of this Appendix 3B, and
comply with section 6i
N/A
6b The date the security holder
resolution under rule 7.1A was
passed
N/A
6c Number of
+
securities issued
without security holder approval
under rule 7.1
N/A
6d Number of
+
securities issued
with security holder approval
under rule 7.1A
N/A
6e Number of
+
securities issued
with security holder approval
under rule 7.3, or another
specific security holder approval
(specify date of meeting)
N/A
6f Number of
+
securities issued
under an exception in rule 7.2
N/A
6g If
+
securities issued under rule
7.1A, was issue price at least 75%
of 15 day VWAP as calculated
under rule 7.1A.3? Include the
+
issue date and both values.
Include the source of the VWAP
calculation.
N/A
6h If
+
securities were issued under
rule 7.1A for non-cash
consideration, state date on
which valuation of
consideration was released to
ASX Market Announcements
N/A
6i Calculate the entity’s remaining
issue capacity under rule 7.1 and
rule 7.1A – complete Annexure 1
and release to ASX Market
Announcements
N/A
7
+
Issue dates
Note: The issue date may be prescribed by
ASX (refer to the definition of issue date in
rule 19.12). For example, the issue date for a
pro rata entitlement issue must comply with
the applicable timetable in Appendix 7A.
Cross reference: item 33 of Appendix 3B.
3 November 2017
Number
+
Class
8 Number and
+
class of all
+
securities quoted on ASX
(including the
+
securities in
section 2 if applicable)
179,223,028 Fully paid ordinary
shares
Number
+
Class
9 Number and
+
class of all
+
securities not quoted on ASX
(including the
+
securities in
section 2 if applicable)
506,839 Performance Share
Rights
10 Dividend policy (in the case of a
trust, distribution policy) on the
increased capital (interests)
N/A
Part 2 - Pro rata issue
11 Is security holder approval
required?
N/A
12 Is the issue renounceable or non-
renounceable?
N/A
13 Ratio in which the
+
securities
will be offered
N/A
14
+
Class of
+
securities to which the
offer relates
N/A
15
+
Record date to determine
entitlements
N/A
16 Will holdings on different
registers (or subregisters) be
aggregated for calculating
entitlements?
N/A
+ See chapter 19 for defined terms.
04/03/2013 Appendix 3B Page 5
ME_138344974_1
17 Policy for deciding entitlements
in relation to fractions
N/A
18 Names of countries in which the
entity has security holders who
will not be sent new offer
documents
Note: Security holders must be told how their
entitlements are to be dealt with.
Cross reference: rule 7.7.
N/A
19 Closing date for receipt of
acceptances or renunciations
N/A
20 Names of any underwriters
N/A
21 Amount of any underwriting fee
or commission
N/A
22 Names of any brokers to the
issue
N/A
23 Fee or commission payable to the
broker to the issue
N/A
24 Amount of any handling fee
payable to brokers who lodge
acceptances or renunciations on
behalf of security holders
N/A
25 If the issue is contingent on
security holders’ approval, the
date of the meeting
N/A
26 Date entitlement and acceptance
form and offer documents will be
sent to persons entitled
N/A
27 If the entity has issued options,
and the terms entitle option
holders to participate on
exercise, the date on which
notices will be sent to option
holders
N/A
28 Date rights trading will begin (if
applicable)
N/A
29 Date rights trading will end (if
applicable)
N/A
30 How do security holders sell
their entitlements in full through
a broker?
N/A
31 How do security holders sell part
of their entitlements through a
broker and accept for the
balance?
N/A
32 How do security holders dispose
of their entitlements (except by
sale through a broker)?
N/A
33
+
Issue date
N/A
Part 3 - Quotation of securities
You need only complete this section if you are applying for quotation of securities
34 Type of
+
securities
(tick one)
(a)
+
Securities described in Part 1
(b)
All other
+
securities
Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid,
employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible
securities
Entities that have ticked box 34(a)
Additional securities forming a new class of securities
Tick to indicate you are providing the information or
documents
35
If the
+
securities are
+
equity securities, the names of the 20 largest holders of the
additional
+
securities, and the number and percentage of additional
+
securities
held by those holders
36
If the
+
securities are
+
equity securities, a distribution schedule of the additional
+
securities setting out the number of holders in the categories
1 - 1,000
1,001 - 5,000
5,001 - 10,000
+ See chapter 19 for defined terms.
04/03/2013 Appendix 3B Page 7
ME_138344974_1
10,001 - 100,000
100,001 and over
37
A copy of any trust deed for the additional
+
securities
Entities that have ticked box 34(b)
38 Number of
+
securities for which
+
quotation is sought
39
+
Class of
+
securities for which
quotation is sought
40 Do the
+
securities rank equally in
all respects from the
+
issue date
with an existing
+
class of quoted
+
securities?
If the additional
+
securities do not
rank equally, please state:
the date from which they do
the extent to which they
participate for the next
dividend, (in the case of a
trust, distribution) or interest
payment
the extent to which they do
not rank equally, other than in
relation to the next dividend,
distribution or interest
payment
41 Reason for request for quotation
now
Example: In the case of restricted securities, end
of restriction period
(if issued upon conversion of
another
+
security, clearly identify
that other
+
security)
Number
+
Class
42 Number and
+
class of all
+
securities quoted on ASX
(including the
+
securities in clause
38)
+ See chapter 19 for defined terms.
04/03/2013 Appendix 3B Page 9
ME_138344974_1
Appendix 3B – Annexure 1
Calculation of placement capacity under rule 7.1 and rule 7.1A for
eligible entities
Introduced 01/08/12 Amended 04/03/13
Part 1
Rule 7.1 – Issues exceeding 15% of capital
Step 1: Calculate “A”, the base figure from which the placement
capacity is calculated
Insert number of fully paid
+
ordinary
securities on issue 12 months before the
+
issue date or date of agreement to issue
Add the following:
• Number of fully paid
+
ordinary securities
issued in that 12 month period under an
exception in rule 7.2
• Number of fully paid
+
ordinary securities
issued in that 12 month period with
shareholder approval
• Number of partly paid
+
ordinary
securities that became fully paid in that
12 month period
Note:
• Include only ordinary securities here –
other classes of equity securities cannot
be added
• Include here (if applicable) the securities
the subject of the Appendix 3B to which
this form is annexed
• It may be useful to set out issues of
securities on different dates as separate
line items
Subtract the number of fully paid
+
ordinary
securities cancelled during that 12 month
period
“A”
Step 2: Calculate 15% of “A”
“B”
0.15
[Note: this value cannot be changed]
Multiply “A” by 0.15
Step 3: Calculate “C”, the amount of placement capacity under rule
7.1 that has already been used
Insert number of
+
equity securities issued
or agreed to be issued in that 12 month
period not counting those issued:
• Under an exception in rule 7.2
• Under rule 7.1A
• With security holder approval under rule
7.1 or rule 7.4
Note:
• This applies to equity securities, unless
specifically excluded – not just ordinary
securities
• Include here (if applicable) the securities
the subject of the Appendix 3B to which
this form is annexed
• It may be useful to set out issues of
securities on different dates as separate
line items
“C”
Step 4: Subtract “C” from [“A” x “B”] to calculate remaining
placement capacity under rule 7.1
“A” x 0.15
Note: number must be same as shown in
Step 2
Subtract “C”
Note: number must be same as shown in
Step 3
Total [“A” x 0.15] – “C”
[Note: this is the remaining placement
capacity under rule 7.1]
+ See chapter 19 for defined terms.
04/03/2013 Appendix 3B Page 11
ME_138344974_1
Part 2
Rule 7.1A – Additional placement capacity for eligible entities
Step 1: Calculate “A”, the base figure from which the placement
capacity is calculated
“A”
Note: number must be same as shown in
Step 1 of Part 1
Step 2: Calculate 10% of “A”
“D”
0.10
Note: this value cannot be changed
Multiply “A” by 0.10
Step 3: Calculate “E”, the amount of placement capacity under rule
7.1A that has already been used
Insert number of
+
equity securities issued
or agreed to be issued in that 12 month
period under rule 7.1A
Notes:
• This applies to equity securities – not
just ordinary securities
• Include here – if applicable – the
securities the subject of the Appendix
3B to which this form is annexed
• Do not include equity securities issued
under rule 7.1 (they must be dealt with
in Part 1), or for which specific security
holder approval has been obtained
• It may be useful to set out issues of
securities on different dates as separate
line items
“E”
Step 4: Subtract “E” from [“A” x “D”] to calculate remaining
placement capacity under rule 7.1A
“A” x 0.10
Note: number must be same as shown in
Step 2
Subtract “E”
Note: number must be same as shown in
Step 3
Total [“A” x 0.10] – “E”
Note: this is the remaining placement
capacity under rule 7.1A
Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.
Other issuers discussed similar conditions around this time
Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.
- FPH — Fisher & Paykel Healthcare Corporation Limited: Notification of Issue of Securities2017-10-24
“+ See chapter 19 for defined terms. 04/03/2013 Appendix 3B Page 1 Rule 2.7, 3.10.3, 3.10.4, 3.10.5 Appendix 3B New issue announcement, application for quotation of additional securities and agreement Information or documents not available now must be given…”
- FPH — Fisher & Paykel Healthcare Corporation Limited: Notification of Issue of Securities2017-10-25
“+ See chapter 19 for defined terms. 04/03/2013 Appendix 3B Page 1 Rule 2.7, 3.10.3, 3.10.4, 3.10.5 Appendix 3B New issue announcement, application for quotation of additional securities and agreement Information or documents not available now must be given…”
- FPH — Fisher & Paykel Healthcare Corporation Limited: Notification of Issue of Securities2017-10-23
“+ See chapter 19 for defined terms. 04/03/2013 Appendix 3B Page 1 Rule 2.7, 3.10.3, 3.10.4, 3.10.5 Appendix 3B New issue announcement, application for quotation of additional securities and agreement Information or documents not available now must be given…”